TNM Supplement
A commentary on uniform use
4th Edition
Published on 23. February 2012
287 pages
978-1-118-38076-5 (ISBN)
Description
The TNM Supplement, 4th Edition, includes new, detailed definitions of anatomical sites, regional lymph nodes, and TNM categories. It answers questions that frequently arise during daily use of the TNM system. Importantly, the TNM Supplement expands on the minimum requirements for pathological classification of individal tumour sites and enumerates the recommended criteria for each. Published in association with the Union for International Cancer Control, it provides oncologists with complementary material related to TNM staging not covered in TNM Classification of Malignant Tumours, 7th Edition.
More details
Other editions
Additional editions
Book
04/2012
4th Edition
Wiley-Blackwell
€47.90
Article exhausted; check for reprint
Content
1 - TNM Supplement: A Commentary on Uniform Use [Seite 5]
1.1 - CONTENTS [Seite 7]
1.2 - Preface [Seite 10]
1.3 - Organizations Associated with the TNM System [Seite 15]
1.4 - National Committees [Seite 15]
1.5 - Acknowledgements [Seite 16]
1.6 - Abbreviations [Seite 17]
1.7 - Chapter 1 EXPLANATORY NOTES - GENERAL [Seite 19]
1.7.1 - The General Rules of the TNM System [Seite 19]
1.7.2 - The TNM Clinical and Pathological Classifications [Seite 24]
1.7.3 - Residual Tumour (R) Classification [Seite 32]
1.7.4 - Additional Descriptors [Seite 36]
1.7.5 - Unknown Primary [Seite 40]
1.7.6 - Staging of Tumours for Which No TNM Classification is Provided [Seite 40]
1.7.7 - Histopathological Grading [Seite 41]
1.8 - Chapter 2 EXPLANATORY NOTES - SPECIFIC ANATOMICAL SITES [Seite 48]
1.8.1 - Head and Neck Tumours [Seite 48]
1.8.2 - Lip and Oral Cavity [Seite 55]
1.8.3 - Digestive System Tumours [Seite 64]
1.8.4 - Lung and Pleural Tumours [Seite 87]
1.8.5 - Bone Tumours [Seite 99]
1.8.6 - Soft Tissue Tumours [Seite 100]
1.8.7 - Skin Tumours [Seite 101]
1.8.8 - Breast Tumours [Seite 107]
1.8.9 - Gynaecological Tumours [Seite 110]
1.8.10 - Urological Tumours [Seite 119]
1.8.11 - Kidney [Seite 123]
1.8.12 - Adrenal Cortex Tumours [Seite 127]
1.8.13 - Ophthalmic Tumours [Seite 128]
1.8.14 - Hodgkin Lymphoma and Non-Hodgkin Lymphomas [Seite 134]
1.8.15 - Appendix [Seite 136]
1.9 - Chapter 3 SITE-SPECIFIC REQUIREMENTS FOR pT AND pN [Seite 152]
1.9.1 - Introduction [Seite 152]
1.9.2 - Head and Neck Tumours [Seite 154]
1.9.3 - Digestive System Tumours [Seite 160]
1.9.4 - Lung and Pleural Tumours [Seite 166]
1.9.5 - Tumours of Bone and Soft Tissues [Seite 168]
1.9.6 - Skin Tumours [Seite 169]
1.9.7 - Breast Tumours [Seite 172]
1.9.8 - Gynaecological Tumours [Seite 174]
1.9.9 - Urological Tumours [Seite 177]
1.9.10 - Adrenal Cortex Tumours [Seite 182]
1.9.11 - Ophthalmic Tumours [Seite 183]
1.9.12 - Hodgkin Lymphoma and Non-Hodgkin Lymphomas [Seite 185]
1.10 - Chapter 4 NEW TNM CLASSIFICATIONS RECOMMENDED FOR TESTING [Seite 189]
1.10.1 - Introduction [Seite 189]
1.10.2 - General [Seite 189]
1.10.3 - Specific [Seite 189]
1.10.4 - Gastrointestinal Sarcomas (other than GISTs) (ICD-O C15-21) [Seite 190]
1.10.5 - Malignant Thymic Epithelial Tumours (Thymoma) (ICD-O C37) [Seite 192]
1.10.6 - Cranial and Facial Bones (ICD-O C41.0, 1) [Seite 192]
1.10.7 - Primary Cutaneous Lymphomas [Seite 195]
1.10.8 - Cutaneous T-Cell Lymphoma (Excluding Lip, Eyelid, Vulva and Penis) (ICD-0 C44.2-7, C63.2) [Seite 195]
1.10.9 - ISLC/EORTC Revision to the Classification of Mycosis Fungoides and Sézary Syndrome [Seite 198]
1.10.10 - Chronic Myeloid Leukaemia [Seite 200]
1.10.11 - Multiple Myeloma [Seite 203]
1.10.12 - Primary Liver Carcinoma in Infants and Children/Hepatoblastoma [Seite 204]
1.10.13 - Adrenal Cortex Carcinoma [Seite 206]
1.10.14 - Liver Metastasis of Colorectal Carcinoma [Seite 206]
1.10.15 - Gastrointestinal Malignant Lymphomas [Seite 207]
1.11 - Chapter 5 OPTIONAL PROPOSALS FOR TESTING NEW TELESCOPIC RAMIFICATIONS OF TNM [Seite 210]
1.11.1 - All Tumour Sites [Seite 211]
1.11.2 - Head and Neck Tumours [Seite 211]
1.11.3 - Digestive System Tumours [Seite 211]
1.11.4 - Liver [Seite 214]
1.11.5 - Lung Tumours [Seite 214]
1.11.6 - Tumours of Bone and Soft Tissues [Seite 216]
1.11.7 - Gynaecological Tumours [Seite 216]
1.11.8 - Urological Tumours [Seite 217]
1.12 - Chapter 6 FREQUENTLY ASKED QUESTIONS [Seite 220]
1.12.1 - General Questions [Seite 220]
1.12.2 - Site-Specific Questions [Seite 229]
1.13 - Index [Seite 261]
1.14 - Plate section [Seite 286]
1.1 - CONTENTS [Seite 7]
1.2 - Preface [Seite 10]
1.3 - Organizations Associated with the TNM System [Seite 15]
1.4 - National Committees [Seite 15]
1.5 - Acknowledgements [Seite 16]
1.6 - Abbreviations [Seite 17]
1.7 - Chapter 1 EXPLANATORY NOTES - GENERAL [Seite 19]
1.7.1 - The General Rules of the TNM System [Seite 19]
1.7.2 - The TNM Clinical and Pathological Classifications [Seite 24]
1.7.3 - Residual Tumour (R) Classification [Seite 32]
1.7.4 - Additional Descriptors [Seite 36]
1.7.5 - Unknown Primary [Seite 40]
1.7.6 - Staging of Tumours for Which No TNM Classification is Provided [Seite 40]
1.7.7 - Histopathological Grading [Seite 41]
1.8 - Chapter 2 EXPLANATORY NOTES - SPECIFIC ANATOMICAL SITES [Seite 48]
1.8.1 - Head and Neck Tumours [Seite 48]
1.8.2 - Lip and Oral Cavity [Seite 55]
1.8.3 - Digestive System Tumours [Seite 64]
1.8.4 - Lung and Pleural Tumours [Seite 87]
1.8.5 - Bone Tumours [Seite 99]
1.8.6 - Soft Tissue Tumours [Seite 100]
1.8.7 - Skin Tumours [Seite 101]
1.8.8 - Breast Tumours [Seite 107]
1.8.9 - Gynaecological Tumours [Seite 110]
1.8.10 - Urological Tumours [Seite 119]
1.8.11 - Kidney [Seite 123]
1.8.12 - Adrenal Cortex Tumours [Seite 127]
1.8.13 - Ophthalmic Tumours [Seite 128]
1.8.14 - Hodgkin Lymphoma and Non-Hodgkin Lymphomas [Seite 134]
1.8.15 - Appendix [Seite 136]
1.9 - Chapter 3 SITE-SPECIFIC REQUIREMENTS FOR pT AND pN [Seite 152]
1.9.1 - Introduction [Seite 152]
1.9.2 - Head and Neck Tumours [Seite 154]
1.9.3 - Digestive System Tumours [Seite 160]
1.9.4 - Lung and Pleural Tumours [Seite 166]
1.9.5 - Tumours of Bone and Soft Tissues [Seite 168]
1.9.6 - Skin Tumours [Seite 169]
1.9.7 - Breast Tumours [Seite 172]
1.9.8 - Gynaecological Tumours [Seite 174]
1.9.9 - Urological Tumours [Seite 177]
1.9.10 - Adrenal Cortex Tumours [Seite 182]
1.9.11 - Ophthalmic Tumours [Seite 183]
1.9.12 - Hodgkin Lymphoma and Non-Hodgkin Lymphomas [Seite 185]
1.10 - Chapter 4 NEW TNM CLASSIFICATIONS RECOMMENDED FOR TESTING [Seite 189]
1.10.1 - Introduction [Seite 189]
1.10.2 - General [Seite 189]
1.10.3 - Specific [Seite 189]
1.10.4 - Gastrointestinal Sarcomas (other than GISTs) (ICD-O C15-21) [Seite 190]
1.10.5 - Malignant Thymic Epithelial Tumours (Thymoma) (ICD-O C37) [Seite 192]
1.10.6 - Cranial and Facial Bones (ICD-O C41.0, 1) [Seite 192]
1.10.7 - Primary Cutaneous Lymphomas [Seite 195]
1.10.8 - Cutaneous T-Cell Lymphoma (Excluding Lip, Eyelid, Vulva and Penis) (ICD-0 C44.2-7, C63.2) [Seite 195]
1.10.9 - ISLC/EORTC Revision to the Classification of Mycosis Fungoides and Sézary Syndrome [Seite 198]
1.10.10 - Chronic Myeloid Leukaemia [Seite 200]
1.10.11 - Multiple Myeloma [Seite 203]
1.10.12 - Primary Liver Carcinoma in Infants and Children/Hepatoblastoma [Seite 204]
1.10.13 - Adrenal Cortex Carcinoma [Seite 206]
1.10.14 - Liver Metastasis of Colorectal Carcinoma [Seite 206]
1.10.15 - Gastrointestinal Malignant Lymphomas [Seite 207]
1.11 - Chapter 5 OPTIONAL PROPOSALS FOR TESTING NEW TELESCOPIC RAMIFICATIONS OF TNM [Seite 210]
1.11.1 - All Tumour Sites [Seite 211]
1.11.2 - Head and Neck Tumours [Seite 211]
1.11.3 - Digestive System Tumours [Seite 211]
1.11.4 - Liver [Seite 214]
1.11.5 - Lung Tumours [Seite 214]
1.11.6 - Tumours of Bone and Soft Tissues [Seite 216]
1.11.7 - Gynaecological Tumours [Seite 216]
1.11.8 - Urological Tumours [Seite 217]
1.12 - Chapter 6 FREQUENTLY ASKED QUESTIONS [Seite 220]
1.12.1 - General Questions [Seite 220]
1.12.2 - Site-Specific Questions [Seite 229]
1.13 - Index [Seite 261]
1.14 - Plate section [Seite 286]
